This document discusses drug delivery systems (DDS). It defines DDS as a formulation or device that enables the introduction of a therapeutic substance into the body and improves its efficacy and safety by controlling the rate, time, and place of drug release. Aspects of DDS include spatial and temporal placement of drugs to target specific organs or tissues. New DDS designs include sustained release oral and injectable forms, transdermal systems, targeted delivery using liposomes and nanoparticles, and transmucosal delivery through inhalation, buccal, rectal, vaginal, and ocular routes. The aims of developing DDS are to increase the number of new drugs coming to market and the number of publications on controlled drug
This document discusses drug delivery systems (DDS). It defines DDS as a formulation or device that enables the introduction of a therapeutic substance into the body and improves its efficacy and safety by controlling the rate, time, and place of drug release. Aspects of DDS include spatial and temporal placement of drugs to target specific organs or tissues. New DDS designs include sustained release oral and injectable forms, transdermal systems, targeted delivery using liposomes and nanoparticles, and transmucosal delivery through inhalation, buccal, rectal, vaginal, and ocular routes. The aims of developing DDS are to increase the number of new drugs coming to market and the number of publications on controlled drug
This document discusses drug delivery systems (DDS). It defines DDS as a formulation or device that enables the introduction of a therapeutic substance into the body and improves its efficacy and safety by controlling the rate, time, and place of drug release. Aspects of DDS include spatial and temporal placement of drugs to target specific organs or tissues. New DDS designs include sustained release oral and injectable forms, transdermal systems, targeted delivery using liposomes and nanoparticles, and transmucosal delivery through inhalation, buccal, rectal, vaginal, and ocular routes. The aims of developing DDS are to increase the number of new drugs coming to market and the number of publications on controlled drug
Definisi • A drug delivery system (DDS) is defined as a formulation or a device that enables the introduction of a therapeutic substance in the body and improves its efficacy and safety by controlling the rate, time, and place of release of drugs in the body • This process includes the administration of the therapeutic product, the release of the active ingredients by the product, and the ubsequent transport of the active ingredients across the biological membranes to the site of action. Aspek Dalam Penghantaran Obat • Spatial placement Penghantaran obat dengan target spesifik organ atau jaringan. • Temporal Placement Penghantarn obat dengan mengatur ritme dan waktu pelepasan obat pada target jaringan Rute Penghantaran obat Desain penghantaran obat baru • Sustained Release Oral Dosage Form • Sustained Release Injectable Dosage Forms • Sustained Release Topical Dosage Forms • Implants And Iuds • Transdermal Drug Delivery System (TDDS) • Targeted Delivery Systems • Liposomes • Nanoparticles • Polymers • Monoclonal Antibodies • Transmucosal Drug Delivery Systems • Inhalation Systems • Buccal Delivery • Rectal Delivery • Vaginal Delivery • Ocular Delivery • Vaccines • Polyclonal Antibodies Aims of DDS Devolepment Number of new molecular entities Number of publications on controlled coming to the market in last decade drug delivery systems over the years Perbedaan : • Extended release ? • Delayed/prolong release ? • Repeat Action ? • Targeted release?